These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21394037)
21. Cardiac ion channels and mechanisms for protection against atrial fibrillation. Grunnet M; Bentzen BH; Sørensen US; Diness JG Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels. Sørensen US; Strøbaek D; Christophersen P; Hougaard C; Jensen ML; Nielsen EØ; Peters D; Teuber L J Med Chem; 2008 Dec; 51(23):7625-34. PubMed ID: 18998663 [TBL] [Abstract][Full Text] [Related]
23. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy. Rivard L; Sinno H; Shiroshita-Takeshita A; Schram G; Leung TK; Nattel S Cardiovasc Res; 2007 Apr; 74(1):104-13. PubMed ID: 17316585 [TBL] [Abstract][Full Text] [Related]
24. Atrial-selective K Ravens U Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160 [TBL] [Abstract][Full Text] [Related]
25. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation. Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400 [TBL] [Abstract][Full Text] [Related]
26. Enhanced Ca Heijman J; Zhou X; Morotti S; Molina CE; Abu-Taha IH; Tekook M; Jespersen T; Zhang Y; Dobrev S; Milting H; Gummert J; Karck M; Kamler M; El-Armouche A; Saljic A; Grandi E; Nattel S; Dobrev D Circ Res; 2023 Apr; 132(9):e116-e133. PubMed ID: 36927079 [TBL] [Abstract][Full Text] [Related]
28. NIP-141, a multiple ion channel blocker, terminates aconitine-induced atrial fibrillation and prevents the rapid pacing-induced atrial effective refractory period shortening in dogs. Hashimoto N; Yamashita T; Fujikura N; Tsuruzoe N Europace; 2007 Apr; 9(4):246-51. PubMed ID: 17350982 [TBL] [Abstract][Full Text] [Related]
29. Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy. Diness JG; Bentzen BH; Sørensen US; Grunnet M J Cardiovasc Pharmacol; 2015 Nov; 66(5):441-8. PubMed ID: 25830485 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological nNOS inhibition modified small-conductance Ca Koya T; Watanabe M; Natsui H; Kadosaka T; Koizumi T; Nakao M; Hagiwara H; Kamada R; Temma T; Anzai T Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H869-H878. PubMed ID: 36149772 [TBL] [Abstract][Full Text] [Related]
31. Novel ion channel targets in atrial fibrillation. Hancox JC; James AF; Marrion NV; Zhang H; Thomas D Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581 [TBL] [Abstract][Full Text] [Related]
32. The effect of apamin, a small conductance calcium activated potassium (SK) channel blocker, on a mouse model of neurofibromatosis 1. Kallarackal AJ; Simard JM; Bailey AM Behav Brain Res; 2013 Jan; 237():71-5. PubMed ID: 22983217 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological modulation of the gating properties of small conductance Ca2+-activated K+ channels alters the firing pattern of dopamine neurons in vivo. Herrik KF; Christophersen P; Shepard PD J Neurophysiol; 2010 Sep; 104(3):1726-35. PubMed ID: 20660424 [TBL] [Abstract][Full Text] [Related]
34. Antiarrhythmic principle of SK channel inhibition in atrial fibrillation. Skibsbye L Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036893 [No Abstract] [Full Text] [Related]
35. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570 [TBL] [Abstract][Full Text] [Related]
36. Hypobaric Hypoxia-Induced Learning and Memory Impairment: Elucidating the Role of Small Conductance Ca Kushwah N; Jain V; Dheer A; Kumar R; Prasad D; Khan N Neuroscience; 2018 Sep; 388():418-429. PubMed ID: 30048783 [TBL] [Abstract][Full Text] [Related]
37. Ca2+-activated K+ channels of small and intermediate conductance control eNOS activation through NAD(P)H oxidase. Gaete PS; Lillo MA; Ardiles NM; Pérez FR; Figueroa XF Free Radic Biol Med; 2012 Mar; 52(5):860-70. PubMed ID: 22210378 [TBL] [Abstract][Full Text] [Related]
38. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation]. Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176 [TBL] [Abstract][Full Text] [Related]
39. Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel. Rosa JC; Galanakis D; Ganellin CR; Dunn PM; Jenkinson DH J Med Chem; 1998 Jan; 41(1):2-5. PubMed ID: 9438015 [No Abstract] [Full Text] [Related]